(AGENPARL) – LONDON (UNITED KINGDOM), ven 18 giugno 2021 Human medicines European public assessment report (EPAR): Opsumit, macitentan, Hypertension, Pulmonary, Date of authorisation: 20/12/2013, Revision: 18, Status: Authorised

Fonte/Source: https://www.ema.europa.eu/en/medicines/human/EPAR/opsumit